These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31940992)

  • 1. Designed Antimicrobial Peptides for Topical Treatment of Antibiotic Resistant Acne Vulgaris.
    Woodburn KW; Jaynes J; Clemens LE
    Antibiotics (Basel); 2020 Jan; 9(1):. PubMed ID: 31940992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Antimicrobial Peptide, RP557, for the Broad-Spectrum Treatment of Wound Pathogens and Biofilm.
    Woodburn KW; Jaynes JM; Clemens LE
    Front Microbiol; 2019; 10():1688. PubMed ID: 31396193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial efficacy of granulysin-derived synthetic peptides in acne vulgaris.
    Lim HS; Chun SM; Soung MG; Kim J; Kim SJ
    Int J Dermatol; 2015 Jul; 54(7):853-62. PubMed ID: 25601314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug Resistance Plasmid pTZC1 Could Be Pooled among
    Koizumi J; Nakase K; Hayashi N; Takeo C; Nakaminami H
    Microbiol Spectr; 2023 Feb; 11(2):e0362822. PubMed ID: 36847559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designed Antimicrobial Peptides Against Trauma-Related Cutaneous Invasive Fungal Wound Infections.
    Woodburn KW; Jaynes JM; Clemens LE
    J Fungi (Basel); 2020 Sep; 6(3):. PubMed ID: 32971819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentobra: A Potent Antibiotic with Multiple Layers of Selective Antimicrobial Mechanisms against Propionibacterium Acnes.
    Schmidt NW; Agak GW; Deshayes S; Yu Y; Blacker A; Champer J; Xian W; Kasko AM; Kim J; Wong GCL
    J Invest Dermatol; 2015 Jun; 135(6):1581-1589. PubMed ID: 25668237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shiunko and Chuoko, topical Kampo medicines, inhibit the expression of gehA encoding the extracellular lipase in Cutibacterium acnes.
    Nakase K; Tashiro A; Yamada T; Ikoshi H; Noguchi N
    J Dermatol; 2019 Apr; 46(4):308-313. PubMed ID: 30803018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of antimicrobial resistance due to the antibiotic treatment of acne vulgaris: a review.
    Patel M; Bowe WP; Heughebaert C; Shalita AR
    J Drugs Dermatol; 2010 Jun; 9(6):655-64. PubMed ID: 20645527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment.
    Woodburn KW; Clemens LE; Jaynes J; Joubert LM; Botha A; Nazik H; Stevens DA
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Evaluation of Existing and Rationally Designed Novel Antimicrobial Peptides for Treatment of Skin and Soft Tissue Infections.
    Ramata-Stunda A; Boroduskis M; Kaktina E; Patetko L; Kalnenieks U; Lasa Z; Rubina M; Strazdina I; Kalnins G; Rutkis R
    Antibiotics (Basel); 2023 Mar; 12(3):. PubMed ID: 36978418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic resistance in the topical treatment of acne vulgaris.
    Leyden JJ
    Cutis; 2004 Jun; 73(6 Suppl):6-10. PubMed ID: 15228128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris.
    Cunliffe WJ; Holland KT; Bojar R; Levy SF
    Clin Ther; 2002 Jul; 24(7):1117-33. PubMed ID: 12182256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Antibiotic Susceptibility Profile of Cutibacterium Acnes in Maltese Patients with Acne.
    Mercieca L; Mangion J; Cefai J; Bezzina T; Schwaiger C; Micallef D; Corso R; Scerri L; Boffa MJ; Caruana P; Clark E; Aquilina S
    J Clin Aesthet Dermatol; 2020 Jun; 13(6):11-16. PubMed ID: 32884613
    [No Abstract]   [Full Text] [Related]  

  • 14. BPX-01 Minocycline Topical Gel Shows Promise for the Treatment of Moderate-to-severe Inflammatory Acne Vulgaris.
    Alexis A; Del Rosso JQ; Desai SR; Downie JB; Draelos ZD; Feser C; Forconi R; Fowler JF; Gold M; Kaufman-Janette J; Lain E; Lee M; Ling M; Shamban AT; Werschler WP; Daniels A
    J Clin Aesthet Dermatol; 2018 Nov; 11(11):25-35. PubMed ID: 30588271
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between quinolone use and resistance of Staphylococcus epidermidis in patients with acne vulgaris.
    Nakase K; Yoshida A; Saita H; Hayashi N; Nishijima S; Nakaminami H; Noguchi N
    J Dermatol; 2019 Sep; 46(9):782-786. PubMed ID: 31254314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antimicrobial effect of CEN1HC-Br against Propionibacterium acnes and its therapeutic and anti-inflammatory effects on acne vulgaris.
    Han R; Blencke HM; Cheng H; Li C
    Peptides; 2018 Jan; 99():36-43. PubMed ID: 29108811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Rationally Designed Multifunctional Antibiotic for the Treatment of Drug-Resistant Acne.
    Ghosh S; Sinha M; Bhattacharyya A; Sadhasivam S; Megha J; Reddy S; Saini S; Singh H; Kumar D; Kaur SP; Mishra M; Usharani D; Ghosh S; Sengupta S
    J Invest Dermatol; 2018 Jun; 138(6):1400-1408. PubMed ID: 29409921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staphylococcus aureus carriage rates and antibiotic resistance patterns in patients with acne vulgaris.
    Delost GR; Delost ME; Armile J; Lloyd J
    J Am Acad Dermatol; 2016 Apr; 74(4):673-8. PubMed ID: 26777099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical antibacterial therapy for acne vulgaris.
    Dreno B
    Drugs; 2004; 64(21):2389-97. PubMed ID: 15481998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne.
    Ozolins M; Eady EA; Avery A; Cunliffe WJ; O'Neill C; Simpson NB; Williams HC
    Health Technol Assess; 2005 Jan; 9(1):iii-212. PubMed ID: 15588555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.